Tripterygium wilfordii Hook F Treatment for Stage IV Diabetic Nephropathy: Protocol for a Prospective, Randomized Controlled Trial

Table 1

Inclusion criteria.

1	Male or female of 40-70 years of age
2	Voluntary participation (signed an informed consent form before any study procedure)
3	Diagnosed in accordance with the diagnostic criteria for DN [29]; consistent with Mogensen stage IV: persistent large amounts of albuminuria () or
4
5	(equivalent to chronic kidney disease stage 1-3)
6	ARB use before and stable condition (no AEs and drug changing)

DN: diabetic nephropathy; eGFR: estimated glomerular filtration rate; CKD-EPI: Chronic Kidney Disease Epidemiology Collaboration; ARB: angiotensin receptor blocker; AEs: adverse events.